A phase II study to evaluate neoadjuvant osimertinib therapy in patients with surgically resectable, EGFRmutant non-small cell lung cancer
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Treatment
Locations
Lone Tree Medical Center
University of Colorado Hospital
Study ID
Protocol Number: 19-0325
More information available at ClinicalTrials.gov: NCT03433469
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers